Editas Medicine (EDIT) Stock Chart & Stock Price History $2.10 +0.17 (+8.81%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$2.12 +0.02 (+1.19%) As of 06/10/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine Stock Price Performance The Editas Medicine (EDIT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 61.33%, with a year-to-date return of 65.35%. In the past month, the stock has increased 44.83%, reflecting recent market activity. As of the latest close, Editas Medicine traded at $2.10 with a market cap of $175.80 million and volume of 2.88 million shares. Five years ago, the stock traded at $25.01, representing a 91.60% decrease over that period. At the time, it had a market cap of $1.44 billion and a volume of 863,747 shares. Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+9.95%1 Month Performance+44.83%3 Month Performance+42.86%Year-To-Date Performance+65.35%1 Year Performance-61.33%5 Year Performance-91.60% EDIT Stock Chart for Wednesday, June, 11, 2025 EDIT Chart by TradingView Editas Medicine Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$1.93$2.10+8.81%$2.23$1.922.88 million shs$175.80 million06/09/2025$1.91$1.93+1.05%$2.02$1.851.22 million shs$161.57 million06/06/2025$1.80$1.91+6.11%$1.97$1.802.45 million shs$159.89 million06/05/2025$1.82$1.80-1.10%$1.98$1.733.18 million shs$150.68 million06/04/2025$1.82$1.82$1.85$1.77866,076 shs$152.36 million06/03/2025$1.77$1.82+2.82%$1.87$1.661.65 million shs$152.36 million06/02/2025$1.74$1.77+2.02%$1.92$1.752.17 million shs$148.17 million05/30/2025$1.83$1.74-5.19%$1.81$1.701.27 million shs$145.24 million05/29/2025$1.87$1.83-2.14%$1.95$1.771.55 million shs$153.20 million05/28/2025$1.65$1.87+13.33%$1.90$1.602.73 million shs$156.54 million Get the Latest News and Ratings for EDIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$1.55$1.65+6.45%$1.79$1.562.52 million shs$138.13 million05/26/2025$1.55$1.55$1.59$1.51949,612 shs$129.76 million05/23/2025$1.62$1.55-4.32%$1.59$1.51949,612 shs$129.76 million05/22/2025$1.50$1.62+8.00%$1.63$1.491.39 million shs$125.57 million05/21/2025$1.64$1.50-8.54%$1.63$1.471.67 million shs$125.57 million05/20/2025$1.49$1.64+10.07%$1.67$1.482.38 million shs$137.29 million05/19/2025$1.51$1.49-1.32%$1.54$1.431.06 million shs$124.73 million05/16/2025$1.40$1.51+8.24%$1.51$1.351.60 million shs$126.40 million05/15/2025$1.38$1.40+1.09%$1.43$1.36969,431 shs$116.78 million05/14/2025$1.50$1.38-8.00%$1.51$1.351.87 million shs$115.52 million05/13/2025$1.54$1.50-2.60%$1.58$1.432.78 million shs$125.57 million05/12/2025$1.45$1.54+6.21%$1.77$1.473.34 million shs$128.91 million Related Companies Taysha Gene Therapies Stock Chart Iovance Biotherapeutics Stock Chart Trevi Therapeutics Stock Chart Keros Therapeutics Stock Chart Bicara Therapeutics Stock Chart Stoke Therapeutics Stock Chart Maze Therapeutics Stock Chart Mind Medicine (MindMed) Stock Chart Bicycle Therapeutics Stock Chart Upstream Bio Stock Chart Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EDIT) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
